King Saud bin Abdulaziz University for Health Sciences
I am Prof. Mahmoud Mansour , Prof of Biochemistry- College of Pharmacy King Saud bin Abdulaziz University for Health Sciences. I received my pharmacy degree from the Al-Azhar University Cairo-Egypt, in 1984, and Ph.D. degree in clinical Biochemistry from the Karolinska Institute, Stockholm Sweden in 1992. From 1996 to 2016, he joined the King Saud University. As a Fellow, I contributed significantly to defining some aspects of the molecular biology of tissue injury and induction of lever toxicity and renal toxicity, with particular focus on role of antioxidant in prevention and treatment of different toxic effects. In addition, I contributed significantly to develop a new strategy for those tumors especially liver. My research has shown that proteasome inhibitor especially irreversible part plays an important role in preventing pathogenic role carcinogenesis of liver by metastatic tumors. I then moved to King Saud bin Abdulaziz University for Health Science, where I continued to work on the pathogenesis of cancer and on issues concerning the cellular and molecular mechanisms of cancer biology and the metastatic process. I am now conducting studies on liver cancer using gankyrin role in liver cancer.
Biography:
Mahmoud Mansour
King Saud bin Abdulaziz University for Health Sciences
I am Prof. Mahmoud Mansour , Prof of Biochemistry- College of Pharmacy King Saud bin Abdulaziz University for Health Sciences. I received my pharmacy degree from the Al-Azhar University Cairo-Egypt, in 1984, and Ph.D. degree in clinical Biochemistry from the Karolinska Institute, Stockholm Sweden in 1992. From 1996 to 2016, he joined the King Saud University. As a Fellow, I contributed significantly to defining some aspects of the molecular biology of tissue injury and induction of lever toxicity and renal toxicity, with particular focus on role of antioxidant in prevention and treatment of different toxic effects. In addition, I contributed significantly to develop a new strategy for those tumors especially liver. My research has shown that proteasome inhibitor especially irreversible part plays an important role in preventing pathogenic role carcinogenesis of liver by metastatic tumors. I then moved to King Saud bin Abdulaziz University for Health Science, where I continued to work on the pathogenesis of cancer and on issues concerning the cellular and molecular mechanisms of cancer biology and the metastatic process. I am now conducting studies on liver cancer using gankyrin role in liver cancer.